NCT07478185 2026-03-17
Prehab for Pancreatic Cancer Surgery
University of Massachusetts, Worcester
Phase NA Not yet recruiting
Clinical Trials
11 trialsNCT07436741 2026-02-27
Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Not yet recruiting
NCT06717295 2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
NCT06388967 2025-12-19
PCDC
City of Hope Medical Center
Recruiting
NCT07277452 2025-12-11
NOTABLE-309
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
NCT06584227 2025-12-08
ACPC
Jinling Hospital, China
Phase 2 Recruiting
NCT03854110 2025-09-11
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine
Geistlich Pharma AG
Phase 1 Active not recruiting
NCT06803771 2025-08-29
SAFE-D
University Hospital Southampton NHS Foundation Trust
Phase NA Recruiting
NCT01834235 2025-05-07
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer
Precision Biologics, Inc
Phase 1/2 Terminated
NCT06822413 2025-04-24
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
NCT06938503 2025-04-22
AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting